{
  "id": 13115431,
  "title": "FDA Approves Teva's Once-Monthly Injectable Olanzapine",
  "url": "https://urgent.news/2026/10/09/fda-approves-tevas-once-monthly-injectable-olanzapine",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T11:17:47.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/fda-approves-tevas-once-monthly-injectable-olanzapine"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Friday, Teva Pharmaceuticals (TEVA) announced that the U.S. FDA has approved WELTRUZA (olanzapine) extended-release injectable suspension for adults with schizophrenia.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Financial Post",
        "title": "Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia",
        "url": "https://urgent.news/2026/10/09/teva-announces-u-s-food-and-drug-administration-fda-approval-of",
        "published": "2026-10-09T11:01:21.000Z"
      },
      {
        "outlet": "CNBC",
        "title": "Teva wins FDA approval for monthly schizophrenia injection Weltruza",
        "url": "https://urgent.news/2026/10/09/teva-wins-fda-approval-for-monthly-schizophrenia-injection-weltruza",
        "published": "2026-10-09T13:14:15.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}